Eric Joseph Daniels - Oct 21, 2021 Form 4/A - Amendment Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Role
Chief Development Officer
Signature
/s/ Sarah Romano, Attorney-in-Fact*
Stock symbol
KPRX
Transactions as of
Oct 21, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
11/22/2021, 03:31 PM
Date Of Original Report
Nov 10, 2021
Next filing
Feb 3, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPRX Common Stock Award +9.52K 9.52K Oct 21, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were omitted from the Reporting Person's Form 4 filed on November 10, 2021.
F2 Received by the Reporting Person in connection with the acquisition by the issuer of all of the outstanding securities of Bayon Therapeutics, Inc. on October 21, 2021.